CXCR4 ( IHC-grade ), CXC Chemokine Receptor 4 Polyclonal Antibody

CXCR4 ( IHC-grade ), CXC Chemokine Receptor 4 Polyclonal Antibody

Catalog Number:
A001456000TMA
Mfr. No.:
7TM0071N-IC
Price:
$528
  • Size:
    100 µl
    Quantity:
    Add to Cart:
      • Overview
        • The CXCR4 receptor antibody is directed against the distal end of the carboxyl-terminal tail of mouse, rat and human CXCR4. It can be used to detect CXCR4 receptors in Western blots in a phosphorylation-sensitive manner. After agonist activation CXCR4 is phosphorylated at S346/S347. Because the CXCR4 antibody detects the same epitope, it no longer binds to the receptor. It detects selectively CXCR4 receptors that have been hot activated and not phosphorylated. Total CXCR4 can be detected in Western blots and immunohistochemistry only after phosphatase treatment. It can also be used to isolate and enrich CXCR4 receptors from brain lysates. It also detects CXCR4 in cultured cells and tissue sections by immunohistochemistry. The CXCR4 antibody has been validated using knockout mice (KO-Validated).

          Please contact us at for specific academic pricing.

      • Properties
        • Host
          rabbit
          Antibody Type
          polyclonal
          Isotype
          IgG
          Reactivity
          human; mouse; rat
          Immunogen
          A synthetic peptide with the sequence KGKRGGHSSVSTESESSSFHSS corresponding to residues 338-359 in human, mouse and rat CXCR4.
          Purification
          Antigen affinity chromatography
          Formulation
          Liquid
          Storage
          Short-term storage at 4°C and long-term storage at -20°C
          Antigen
          CXCR4, CXC Chemokin Receptor 4 (UniProt:P61073 (human), P70658 (mouse), O08565 (rat))

          * This product is intended for research use only.

      • Applications
        • Application
          WB; ICC; IHC
        • Application Dilutions
          Western Blot (WB) 1:1000
          Immunocytochemistry (ICC) 1:200
          Immunohistochemistry (IHC) 1:100
      • Reference
        • Stumm RK, Rummel J, Junker V, Culmsee C, Pfeiffer M, Krieglstein J, Höllt V, Schulz S. A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J Neurosci. 2002 Jul 15;22(14):5865-78.
          Stumm RK, Zhou C, Ara T, Lazarini F, Dubois-Dalcq M, Nagasawa T, Höllt V, Schulz S. CXCR4 regulates interneuron migration in the developing neocortex. J Neurosci. 2003 Jun 15;23(12):5123-30.
          Fischer T, Nagel F, Jacobs S, Stumm R, Schulz S. Reassessment of CXCR4 chemokine receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-2. PLoS One. 2008;3(12):e4069. doi: 10.1371/journal.pone.0004069. Epub 2008 Dec 31.
          Sánchez-Alcañiz JA, Haege S, Mueller W, Pla R, Mackay F, Schulz S, López-Bendito G, Stumm R, Marín O. Cxcr7 controls neuronal migration by regulating chemokine responsiveness. Neuron. 2011 Jan 13;69(1):77-90. doi: 10.1016/j.neuron.2010.12.006.
          Gourni E, Demmer O, Schottelius M, D'Alessandria C, Schulz S, Dijkgraaf I, Schumacher U, Schwaiger M, Kessler H, Wester HJ. PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent. J Nucl Med. 2011 Nov;52(11):1803-10. doi: 10.2967/jnumed.111.098798.
          Otte M, Kliewer A, Schütz D, Reimann C, Schulz S, Stumm R. CXCL14 is no direct modulator of CXCR4. FEBS Lett. 2014 Dec 20;588(24):4769-75. doi: 10.1016/j.febslet.2014.11.009. Epub 2014 Nov 18.
          Saaber F, Schütz D, Miess E, Abe P, Desikan S, Ashok Kumar P, Balk S, Huang K, Beaulieu JM, Schulz S, Stumm R. ACKR3 Regulation of Neuronal Migration Requires ACKR3 Phosphorylation, but Not β-Arrestin. Cell Rep. 2019 Feb 5;26(6):1473-1488.e9. doi: 10.1016/j.celrep.2019.01.049. PubMed PMID: 30726732.

    Note: If you don't receive our verification email, do the following:

  • Copyright © Amerigo Scientific. All rights reserved.